With a growing shift towards natural and organic products, the Company has positioned itself strongly in the field of human health and wellness. EID is the first and amongst few with a dedicated R&D wing and cane breeding program. Its innovative programs in sugarcane cultivation methods have set industry benchmarks in yield and recovery. At the CMP of Rs. 200.55, the stock trades at ~6 times FY21 EPS of Rs. 34. Hence, we recommend a BUY on the stock with a Target Price of Rs. 272 with an upside potential of ~36% from the current level with an investment horizon of 9-12 months.